Universal-Beteiligungs- und Servicegesellschaft
CSTL icon

Universal-Beteiligungs- und Servicegesellschaft’s Castle Biosciences CSTL Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$602K Sell
25,221
-9,166
-27% -$204K ﹤0.01% 1734
2026
Q1 		$844K Buy
34,387
+5,030
+17% +$165K ﹤0.01% 1566
2025
Q4 		$1.14M Sell
29,357
-526
-2% -$17K ﹤0.01% 1453
2025
Q3 		$680K Sell
29,883
-24,727
-45% -$502K ﹤0.01% 1667
2025
Q2 		$1.12M Buy
54,610
+42,857
+365% +$793K ﹤0.01% 1453
2025
Q1 		$235K Buy
+11,753
New +$291K ﹤0.01% 1842

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's CSTL Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Castle Biosciences (CSTL) stake by 27% in Q2 2026, selling an estimated $204K and leaving 25,221 shares worth $602K. The position accounts for ﹤0.01% of the portfolio, ranked #1734.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in CSTL in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.14M in Q4 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 25,221 shares of Castle Biosciences worth $602K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 9,166 Castle Biosciences shares in Q2 2026, an estimated $204K.
  • Castle Biosciences made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1734 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Castle Biosciences in Q1 2025 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Castle Biosciences position peaked at $1.14M in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.